SimvastatinDipeptidyl-Peptidase IV InhibitorsPyrazinesTriazolesHydroxymethylglutaryl-CoA Reductase InhibitorsDipeptidyl Peptidase 4Hypoglycemic AgentsGlucagon-Like Peptide 1VenomsMetforminDiabetes Mellitus, Type 2AdamantaneAnticholesteremic AgentsIncretinsHemizygoteGlipizideAdenosine Deaminase InhibitorsDrug SubstitutionHepatic InsufficiencyBlood GlucoseLovastatinDrug Therapy, CombinationAzetidinesHemoglobin A, Glycosylated1-DeoxynojirimycinSulfonylurea CompoundsHypolipidemic AgentsHeptanoic AcidsHypercholesterolemiaRhabdomyolysisCross-Over StudiesPyrrolidinesPostprandial PeriodDouble-Blind MethodTreatment OutcomeLipidsPravastatinIslet Amyloid PolypeptideAdministration, OralMevalonic AcidPyrrolesSulfuric Acid EstersDrug InteractionsInsulinBody WeightCyclizationIslamFluorobenzenesInsulin, Long-ActingCholesterol, LDLCholesterolNitrilesGlycemic IndexDose-Response Relationship, DrugAnti-Inflammatory AgentsDrug CombinationsThiazolidinedionesPolyisoprenyl PhosphatesHyperglycemiaColoradoArea Under Curvealpha-GlucosidasesPeptidesDisease Models, AnimalBiological MarkersFastingHypoglycemiaBiotransformationPancreatitisNiacinGlucosidesDrinking BehaviorTime FactorsInsulin-Secreting CellsDrug Evaluation, PreclinicalC-Reactive ProteinAdenosine DeaminaseRats, Sprague-DawleyPancreasPilot ProjectsLiver Function Tests